5AM Ventures V, L.P.

CIK: 0001674324

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)13 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TRDA

Entrada Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (13 total)

TRDA
Entrada Therapeutics, Inc.
Aug 7, 2026
Sale(S)
Direct
52.3K shares at avg. $6.85$358K
TRDA
Entrada Therapeutics, Inc.
Aug 6, 2026
Sale(S)
Direct
10.5K shares at avg. $7.00$73K
TRDA
Entrada Therapeutics, Inc.
Jul 31, 2026
Sale(S)
Direct
1.7K shares at avg. $6.85$12K
TRDA
Entrada Therapeutics, Inc.
Jul 30, 2026
Sale(S)
Direct
114.8K shares at avg. $6.93$795K
TRDA
Entrada Therapeutics, Inc.
Nov 14, 2025
Sale(S)
Direct
200K shares at avg. $8.80$1.8M
TRDA
Entrada Therapeutics, Inc.
Jul 9, 2025
Sale(S)
Direct
20.1K shares at avg. $7.50$151K
TRDA
Entrada Therapeutics, Inc.
Jul 9, 2025
Sale(S)
Indirect
6.9K shares at avg. $7.50$52K
TRDA
Entrada Therapeutics, Inc.
Jul 1, 2025
Sale(S)
Direct
18.6K shares at avg. $7.12$132K
TRDA
Entrada Therapeutics, Inc.
Jul 1, 2025
Sale(S)
Indirect
6.4K shares at avg. $7.12$46K
TRDA
Entrada Therapeutics, Inc.
Jun 30, 2025
Sale(S)
Direct
18.6K shares at avg. $6.81$127K
TRDA
Entrada Therapeutics, Inc.
Jun 30, 2025
Sale(S)
Indirect
6.4K shares at avg. $6.81$44K
TRDA
Entrada Therapeutics, Inc.
Jun 27, 2025
Sale(S)
Direct
55.7K shares at avg. $6.91$385K
TRDA
Entrada Therapeutics, Inc.
Jun 27, 2025
Sale(S)
Indirect
19.3K shares at avg. $6.91$133K

		Type	Shares	Price		Ownership
Aug 7, 2026	TRDA Entrada Therapeutics, Inc.	Sale(S)	52,317	$6.85	$358,371	Direct
Aug 6, 2026	TRDA Entrada Therapeutics, Inc.	Sale(S)	10,494	$7.00	$73,458	Direct
Jul 31, 2026	TRDA Entrada Therapeutics, Inc.	Sale(S)	1,718	$6.85	$11,768	Direct
Jul 30, 2026	TRDA Entrada Therapeutics, Inc.	Sale(S)	114,756	$6.93	$795,259	Direct
Nov 14, 2025	TRDA Entrada Therapeutics, Inc.	Sale(S)	200,000	$8.80	$1,760,000	Direct
Jul 9, 2025	TRDA Entrada Therapeutics, Inc.	Sale(S)	20,065	$7.50	$150,528	Direct
Jul 9, 2025	TRDA Entrada Therapeutics, Inc.	Sale(S)	6,935	$7.50	$52,026	Indirect
Jul 1, 2025	TRDA Entrada Therapeutics, Inc.	Sale(S)	18,578	$7.12	$132,324	Direct
Jul 1, 2025	TRDA Entrada Therapeutics, Inc.	Sale(S)	6,422	$7.12	$45,741	Indirect
Jun 30, 2025	TRDA Entrada Therapeutics, Inc.	Sale(S)	18,578	$6.81	$126,566	Direct
Jun 30, 2025	TRDA Entrada Therapeutics, Inc.	Sale(S)	6,422	$6.81	$43,751	Indirect
Jun 27, 2025	TRDA Entrada Therapeutics, Inc.	Sale(S)	55,735	$6.91	$385,129	Direct
Jun 27, 2025	TRDA Entrada Therapeutics, Inc.	Sale(S)	19,265	$6.91	$133,121	Indirect

1-13 of 13 transactions

About 5AM Ventures V, L.P.

5AM Ventures V, L.P. (SEC CIK 0001674324) files insider reports with the SEC as 10% Owner of Entrada Therapeutics, Inc. (TRDA).

Signal8 holds 5 ownership filings by 5AM Ventures V, L.P., all Form 4s, filed between Jul 1, 2025 and Aug 10, 2026. Those filings report 13 transactions, from Jun 27, 2025 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on 5AM Ventures V, L.P.'s filings is in SAN FRANCISCO, CA.

Recent filings by 5AM Ventures V, L.P.

Aug 7, 2026: Open-market sale of TRDA shares (Form 4, code S).
Aug 6, 2026: Open-market sale of TRDA shares (Form 4, code S).
Jul 31, 2026: Open-market sale of TRDA shares (Form 4, code S).
Jul 30, 2026: Open-market sale of TRDA shares (Form 4, code S).
Nov 14, 2025: Open-market sale of TRDA shares (Form 4, code S).

Other insiders filing for Entrada Therapeutics, Inc. (TRDA)

MPM BIOVENTURES 2018, L.P., 10% Owner
MPM BioVentures 2014, L.P., 10% Owner
Doshi Dipal, CEO
Dowden Nathan J, President & COO
Sethuraman Natarajan, President, Research & Develop.
WENTWORTH KORY JAMES, Chief Financial Officer

How to read Form 4 transaction codes